Former Credit Suisse boss launches new fund to invest in Human Longevity
Former Credit Suisse chief executive Tidjane Thiam has launched a new fund to invest in life sciences firm Human Longevity after dropping plans to merge his blank cheque company with the California-based start-up.
Thiam co-founded the Free Tiger Fund to invest in late-stage venture groups, including Human Longevity, previously in advanced talks to merge with his special purpose acquisition company, Freedom Acquisition Corp.
However, Thiam told the Financial Times that Human Longevity was not ready to be listed on the stock exchange, which led to Freedom merging with another firm Complete Solaria on Monday.
This story originally appeared on: Financial Times - Author:Emma Dunkley
